Search results
Hybrid working works: huge study reveals no drop in productivity
Nature· 6 days agoHear the biggest stories from the world of science | 12 June 2024
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg via Yahoo Finance· 4 hours ago(Bloomberg) -- The Food and Drug Administration delayed a breast- and lung-cancer trial of an...
Expats revel in Dragon Boat Festival at SIP
China Daily· 6 days agoExpats from Canada, India, Iran, Bangladesh and Pakistan visited Suzhou Industrial Park (SIP) on June 10 and experienced a day filled with cultural adventures. Admiring the ...
Quectel Wireless Solutions Leads Three Growth Stocks With High Insider Ownership On The Chinese...
Simply Wall St. via Yahoo Finance· 13 hours agoAmidst a backdrop of deflationary pressures and cautious consumer sentiment in China, investors may...
More good news for coffee drinkers from a study of sitting and sipping
Washington Post· 10 hours agoSedentary coffee drinkers had a 24 percent reduced risk of mortality compared with those who sat for...
High Insider Ownership Growth Stocks On Chinese Exchanges In June 2024
Simply Wall St. via Yahoo Finance· 22 hours agoAs of June 2024, the Chinese market has shown signs of deflationary pressures and a cautious...
Africa switches from carbon sink to carbon source
Nature· 4 days agoThe continent now emits more greenhouse gases than it absorbs, and contributes 40% of global emissions from agriculture.
Unease as US drug agency weighs its use of independent scientists
Nature· 4 days agoAfter several controversial drug approvals, the US Food and Drug Administration is mulling changes...
Three Growth Companies With High Insider Ownership On Chinese Exchanges Showcasing 27% Revenue...
Simply Wall St. via Yahoo Finance· 4 days agoAmidst a backdrop of mixed global economic signals, China's markets have shown resilience with key...
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
FierceBiotech· 7 hours agoThe FDA has slammed the brakes on MediLink Therapeutics’ trial of a BioNTech-partnered antibody-drug...